Telix Pharmaceutical US ADS - Momentum Remains Strong, Offering Would Triple Its Cash Base

328 Views12 Jun 2024 11:00

Telix Pharmaceuticals (TLX AU) is looking to raise around US$190m in its US ADS listing. The bookrunners on the deal are Jefferies, Morgan Stanley, Truist Securities, and William Blair.

What is covered in the Full Insight:

Deal terms and dynamics
Updates since previous note
Past deal performances
Upcoming IPO and stock valuation
Concluding thoughts

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 5-minute read)

Discussions

(Paid Plans Only)

Top 5%

Clarence Chu

APAC IPOs & Placements

Aequitas Research

EquitiesEquity Capital Markets

View Full Profile

Price Chart(Sign Up to Access)

Insight Stream